Top compounds associated with response to SEC62


Feature Type Standardized
Nominal ANOVA
mRNA Rapamycin GDSC1000 pan-cancer AAC 0.21 1e-05
mRNA A-443654 GDSC1000 pan-cancer AAC 0.21 2e-05
mRNA alisertib CTRPv2 pan-cancer AAC -0.13 2e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.13 7e-05
mRNA ML311 CTRPv2 pan-cancer AAC -0.13 8e-05
mRNA narciclasine CTRPv2 pan-cancer AAC -0.12 0.0001
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0002
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA brivanib CTRPv2 pan-cancer AAC -0.13 0.0002
Download CSV